Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00271388 · ClinicalTrials.gov registry record · NA

Vestibular Stimulation to Treat Hemispatial Neglect

A NA study of Stroke and Hemispatial Neglect, sponsored by VA Office of Research and Development.

Completed
Registry status
NA
Development phase
2
Enrollment target
1
Study location

NCT00271388 is a NA study of Stroke and Hemispatial Neglect that has completed, run by VA Office of Research and Development. The registered enrollment target is 2 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00271388, a NA study of Stroke and Hemispatial Neglect, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
NA
Development phase
2 participants
Enrollment target
1
Study location

Study Summary

The purpose of the current proposal is to pilot a new and potentially improved treatment for neglect. The procedure involves the delivery of transcutaneous small-amplitude current to the vestibular nerves that lie directly below the mastoid bones.

Interventions

  • DEVICE Transcutaneous current to the vestibular nerve

Study Locations (1)

Massachusetts

  • VA Medical Center, Jamaica Plain Campus - Boston

Trial Details

FieldValue
Enrollment Target 2 participants
Start Date 2006-01
Est. Completion 2008-12
Phase NA

Sponsor

VA Office of Research and Development

1,668 total trials

What the Registry Record Tells You About NCT00271388

The ClinicalTrials.gov registry entry for NCT00271388 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which Transcutaneous current to the vestibular nerve is the first listed.

NCT00271388 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT00271388 about?

NCT00271388 is a clinical study titled "Vestibular Stimulation to Treat Hemispatial Neglect". The purpose of the current proposal is to pilot a new and potentially improved treatment for neglect. The procedure involves the delivery of transcutaneous small-amplitude current to the vestibular nerves that lie directly below the mastoid bones.

What is the current status of trial NCT00271388?

This trial is currently completed. It is a NA study. The enrollment target is 2 participants. The study started on 2006-01. Estimated completion is 2008-12.

What conditions does trial NCT00271388 study?

This clinical trial studies the following conditions: Stroke, Hemispatial Neglect.

What interventions are being tested in trial NCT00271388?

The interventions under investigation include: Transcutaneous current to the vestibular nerve (DEVICE).

Who is sponsoring clinical trial NCT00271388?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00271388 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.